Valor Intrínseco del S&P y Nasdaq Contáctenos

Aclarion, Inc. ACONW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
46/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Aclarion, Inc. (ACONW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Los analistas estiman Beneficio por acción (EPS) de $-7,371.68 y ingresos de $0.00B para el próximo año fiscal.

Historial de Beneficio por acción (EPS): 2024: real $-7,480.21 vs est $-7,371.68 (no alcanzó -1.5%). 2025: real $-13.61 vs est $-15.13 (superó +10%). Precisión del analista: 94%.

Estimaciones de BPA — ACONW

94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$7,480.21 vs Est –$7,371.68 ▼ 1.5% off
2025 Actual –$13.61 vs Est –$15.13 ▲ 11.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Estimaciones de Ingresos — ACONW

89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.000B vs Est $0.000B ▼ 20.3% off
2025 Actual $0.000B vs Est $0.000B ▼ 1.7% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
Envíanos un mensaje